Avanos Medical (AVNS) Accumulated Expenses (2013 - 2026)

Avanos Medical has disclosed Accumulated Expenses across 14 years of filings, most recently posting $57.6 million for Q1 2026.

• Accumulated Expenses for Q1 2026 came in at $57.6 million, down 19.33% year-over-year; the trailing twelve-month figure through Mar 2026 was $57.6 million (down 19.33% YoY), and the FY2025 annual result was $91.3 million, changed 0.0% from the prior year.
• Accumulated Expenses came in at $57.6 million for Q1 2026 at Avanos Medical, down from $91.3 million in the prior quarter.
• In the past five years, Accumulated Expenses ranged from a high of $97.8 million in Q4 2022 to a low of $57.6 million in Q1 2026.
• The 5-year median for Accumulated Expenses is $79.5 million (2024), against an average of $79.7 million.
• Across the five-year window, Accumulated Expenses jumped 43.61% in 2022 and declined 19.33% in 2026, its largest moves.
• Avanos Medical's Accumulated Expenses stood at $97.8 million in 2022, then slipped by 4.7% to $93.2 million in 2023, then slipped by 2.04% to $91.3 million in 2024, then changed by 0.0% to $91.3 million in 2025, then slumped by 36.91% to $57.6 million in 2026.
• The last three Accumulated Expenses figures came in at $57.6 million (Q1 2026), $91.3 million (Q4 2025), and $74.8 million (Q3 2025), per Business Quant data.